Buy Bulk CJC-1295 W-DAC 2mg (No Promo Codes)

CJC-1295 W-DAC 2mg is a synthetic analog of human growth hormone-releasing hormone (GHRH) and includes a drug affinity complex (DAC) to enable extended half-life. This formulation allows CJC-1295 to bind to endogenous albumin, leading to sustained levels in circulation, which makes it highly suitable for in vitro laboratory research purposes only.¹

Studies in animal models have shown that a single administration of CJC-1295 can elevate insulin-like growth factor-I (IGF-I) levels for extended periods, even days after the initial application.² However, CJC-1295 W-DAC 2mg is strictly intended for controlled laboratory environments and is not approved for human or veterinary use.

Research into CJC-1295 has focused on its impact on growth hormone pulsatility, body composition, and metabolism. In laboratory settings, CJC-1295 is used to increase endogenous growth hormone levels by stimulating the pituitary gland’s pulsatile release.¹ A 2006 study conducted by Alba et al. investigated the effects of CJC-1295 in GHRH knockout mice, observing significant changes in growth metrics. These findings underscore CJC-1295’s potential as a tool in research focusing on body composition and growth mechanisms.³

Additional research suggests that analogs like CJC-1295 may have applications in studying hormone pathways without disrupting normal circadian rhythms. However, it is critical to emphasize that all research conducted with CJC-1295 W-DAC 2mg must adhere to in vitro protocols, and the peptide is provided strictly for experimental use in laboratory settings only.

Further, studies on growth hormone pathways indicate that GHRH analogs may affect ovarian cell differentiation in response to gonadotropins. In controlled experiments on rat ovarian granulosa cells, growth hormone was observed to enhance FSH-induced differentiation. These findings support CJC-1295’s potential value in research related to endocrine and reproductive physiology.⁴

Product Information: CJC-1295 W-DAC is available as a lyophilized powder at a concentration of 2 mg per vial. It is intended strictly for in vitro laboratory research only and must not be used for any human or veterinary applications.

Important Compliance Notice: CJC-1295 W-DAC is designated solely for laboratory use and is not approved for human or animal use. All handling and experimentation with CJC-1295 W-DAC must occur in compliance with applicable laboratory research protocols.

References:
1. Jetté L et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005 Jul;146(7):3052-8.
2. Benquet C, Castaigne JP, Pham K, Robitaille M, Frohman LA. CJC-1295 (DAC-GRF), a long-acting GRF analog, enhances pulsatile GH secretion, increases IGF-1 levels, and restores linear growth (Abstract). 86th Annual Meeting of The Endocrine Society, 2004, p. P3-109.
3. Alba M et al. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4.
4. Jia XC, Kalmijn J, Hsueh AJ. Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology. 1986 Apr;118(4):1401-9.